Table 4.
Treatments | Cost/Cycle |
---|---|
1st line chemotherapy: intervention therapy | |
Induction (cytarabine + daunorubicin + midostaurin) | € 6,521.41 |
Consolidation (high dose cytarabine + midostaurin) | € 6,859.79 |
Maintenance (midostaurin) | € 12,813.65 |
1st line chemotherapy: Comparator treatment | |
7 + 3 (cytarabine + daunorubicin) |
€ 114.59 |
High dose cytarabine | € 452.97 |
2nd line chemotherapy | |
FLAG-IDA (fludarabine + cytarabine + idarubicin) |
€ 1,340.81 |
MEC (mitoxantrone + etoposide + cytarabine) |
€ 514.44 |
Other treatmentsa | |
7 + 3 (cytarabine + idarubicin) |
€ 786.53 |
Notes: aIn the opinion of experts, regimens based on cytarabine and idarubicin are also common in induction therapy in Spain, so a sensitivity analysis was carried out that included the costs of induction therapy with idarubicin and daunorubicin.